secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medpace Holdings, Inc. (MEDP)
CIK:        0001668397
Form:       8-K
Filed at:   2022-03-16T23:59:59+00:00
Accession:  0000950170-22-003943
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medpace increases credit facility to $250M and expands share buyback by $200M
-----------------------------------------------------------------------------

- Amendment No. 4 raises line of credit from $50M to $250M with PNC Bank, maturing March 31, 2023.
- Board approved $200M increase to stock repurchase program; 1,782,136 shares repurchased since Feb 11, 2022.
- Repurchases reduced outstanding shares by ~5%; 33,723,904 shares outstanding as of March 14, 2022.
- Interest options include Base Rate or Term SOFR +1.00%; anti-money laundering compliance updated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1668397/000095017022003943/0000950170-22-003943-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1668397/000095017022003943/medp-20220315.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-003943

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer